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The etiology of multiple sclerosis (MS) and its pathogen-
esis are unclear in spite of being the topic of much research
for many years. Neuropathological examinations provide
undisputable evidence of inflammatory processes in acute
demyelinating lesions in MS. This by itself is not surpris-
ing, since even if these inflammatory processes are sec-
ondary to the initial lesion, they may still have unfavorable
consequences. In fact, the beneficial effects of high-dose
steroid administration in speeding up the recovery from
acute MS relapses seem to support this view.
The assumption that inflammation has a central role in
the disease, rather than an epiphenomenon, has persisted
for decades. This assumption that inflammation processes
underlie the neurodegenerative process in MS was the basis
for chronic therapy with steroids, which has been popular
in the past. However, a more critical examination showed
this to be an unrewarding treatment.
Inflammation is a term used to describe many processes,
sometime complementing and at other time opposing each
other, some beneficial and others not. Therefore, a sys-
tematic study regarding the role of inflammation in MS
should be made in a more focused way. The positive
effects of b-interferons (which are anti-inflammatory)
support a damaging role of inflammation in acute relapses.
However, by the same token, their inefficacy during the
secondary progenies phase argues against an inflammatory
role in the chronic stage.
The neurodegenerative component of MS may or may
not be a consequence of inflammation. Neither corticoste-
roids nor specific anti-inflammatory agents like interferons
are effective in the chronic progressive stage of MS.
Whether other focused anti-inflammatory process modu-
lation could be beneficial remains to be seen. However, the
development of such drugs depends on a more refined
definition of the inflammatory process components and
discovery of specific targeted interventions. For the time
being, the jury is still out: Is MS primarily an inflammatory
disorder, where the neurodegeneration is a consequence, or
is it primarily a neurodegenerative disorder, in which
inflammatory responses are secondary, occurring at the
beginning but later die out.
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